New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Machine learning can predict rate of memory change

Machine learning can predict rate of memory change

by Alzheimer's Research UKIn new research published today, researchers have created a machine learning algorithm that is able to form two distinct groups of people who have early memory probl
Neurology March 07,2024
Machine learning can predict rate of memory change

Machine learning can predict rate of memory change

by Alzheimer's Research UKIn new research published today, researchers have created a machine learning algorithm that is able to form two distinct groups of people who have early memory probl
Neurology March 07,2024
Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

by Courtney Caprara,University of PittsburghIndividuals with mild cognitive impairment have a new resource in Pittsburgh with the recently establishedBrain Training and Exercise(BRiT
Neurology March 07,2024
Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

by Courtney Caprara,University of PittsburghIndividuals with mild cognitive impairment have a new resource in Pittsburgh with the recently establishedBrain Training and Exercise(BRiT
Neurology March 07,2024
Meditation and music may help reverse early memory loss in adults at risk for Alzheimer's disease

Meditation and music may help reverse early memory loss in adults at risk for Alzheimer's disease

by IOS PressIn a recent study of adults with early memory loss, a West Virginia University research team lead by Dr. Kim Innes found that practice of a simple meditation or music listening progra
Neurology March 07,2024
Meditation and music may help reverse early memory loss in adults at risk for Alzheimer's disease

Meditation and music may help reverse early memory loss in adults at risk for Alzheimer's disease

by IOS PressIn a recent study of adults with early memory loss, a West Virginia University research team lead by Dr. Kim Innes found that practice of a simple meditation or music listening progra
Neurology March 07,2024
Experimental drug shows promise in treating Alzheimer's disease

Experimental drug shows promise in treating Alzheimer's disease

by American Society of AnesthesiologistsAn experimental drug shows promise in treating Alzheimer's disease by preventing inflammation and removing abnormal protein clumps in the brain that are ass
Neurology March 07,2024
Experimental drug shows promise in treating Alzheimer's disease

Experimental drug shows promise in treating Alzheimer's disease

by American Society of AnesthesiologistsAn experimental drug shows promise in treating Alzheimer's disease by preventing inflammation and removing abnormal protein clumps in the brain that are ass
Neurology March 07,2024
Researchers identify genetic factors that contribute to Alzheimer's disease

Researchers identify genetic factors that contribute to Alzheimer's disease

by Boston University School of MedicineResearchers have identified several new genes responsible for Alzheimer's disease (AD) including those leading to functional and structural changes in t
Neurology March 07,2024
Researchers identify genetic factors that contribute to Alzheimer's disease

Researchers identify genetic factors that contribute to Alzheimer's disease

by Boston University School of MedicineResearchers have identified several new genes responsible for Alzheimer's disease (AD) including those leading to functional and structural changes in t
Neurology March 07,2024
Possible pathway to new therapy for Alzheimer's disease

Possible pathway to new therapy for Alzheimer's disease

by Boston University School of MedicineResearchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of bet
Neurology March 07,2024
Possible pathway to new therapy for Alzheimer's disease

Possible pathway to new therapy for Alzheimer's disease

by Boston University School of MedicineResearchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of bet
Neurology March 07,2024
Taking proton pump inhibitors not linked to higher dementia risk

Taking proton pump inhibitors not linked to higher dementia risk

by American Geriatrics SocietyProton pump inhibitors (PPIs) are medicines commonly prescribed to treat acid-related digestive problems, including gastroesophageal reflux disease (or GERD). As of
Neurology March 07,2024
Taking proton pump inhibitors not linked to higher dementia risk

Taking proton pump inhibitors not linked to higher dementia risk

by American Geriatrics SocietyProton pump inhibitors (PPIs) are medicines commonly prescribed to treat acid-related digestive problems, including gastroesophageal reflux disease (or GERD). As of
Neurology March 07,2024
Using herpes drugs to slow down Alzheimer's disease could become reality

Using herpes drugs to slow down Alzheimer's disease could become reality

by Umea UniversityThe first clinical study to investigate if herpes virus drugs can have an effect on fundamental Alzheimer's disease processes has been launched at Umeå University in Sweden.
Neurology March 07,2024
Using herpes drugs to slow down Alzheimer's disease could become reality

Using herpes drugs to slow down Alzheimer's disease could become reality

by Umea UniversityThe first clinical study to investigate if herpes virus drugs can have an effect on fundamental Alzheimer's disease processes has been launched at Umeå University in Sweden.
Neurology March 07,2024
A spherical brain mapping of MR images for the detection of Alzheimer's disease

A spherical brain mapping of MR images for the detection of Alzheimer's disease

by Bentham Science PublishersDiagnosis, treatment and care of dementia is one of the major concerns in neurology research and associated healthcare programs. Dementia affects older age groups with a g
Neurology March 07,2024
A spherical brain mapping of MR images for the detection of Alzheimer's disease

A spherical brain mapping of MR images for the detection of Alzheimer's disease

by Bentham Science PublishersDiagnosis, treatment and care of dementia is one of the major concerns in neurology research and associated healthcare programs. Dementia affects older age groups with a g
Neurology March 07,2024
Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe
Neurology March 07,2024
Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe
Neurology March 07,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com